Home
Howard W. Robin, President & CEO: Nektar Therapeutics NKTR Sell · Filed 24/08/20
Trade details
- Type
- Insider sale
- Amount
- $19,047.68
- Shares · price
- 14,881 sh · $1.28 a share
- Held after
- 848,358 sh
- Trade date
- 24/08/19
- Filed
- 24/08/20
- Days to filing
- 1 days
Sold 1.7% of holdings
- Share of holding sold
- 1.7%
Nektar Therapeutics trades, last 26 weeks
What else happened in Nektar Therapeutics around then
Filed or reported within 30 days of the trade day · 24/07/20~24/09/18Howard W. Robin's recent trades
- Howard W. Robin
Planned saleNektar Therapeutics
Planned saleNektar Therapeutics
NKTR
$30.1K
418 sh
$30.1K
Filed 08/18
Traded 08/18
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$334.5K
5,500 sh
$334.5K
Filed 06/18
Traded 06/17
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$318K
5,303 sh
$318K
Filed 06/18
Traded 06/16
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$285.2K
4,697 sh
$285.2K
Filed 06/18
Traded 06/16
- Howard W. Robin
Sell10b5-1 planNektar Therapeutics
Sell10b5-1 planNektar Therapeutics
NKTR
$277.4K
4,500 sh
$277.4K
Filed 06/18
Traded 06/17